Atlas Trials

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Clinical trial NCT01690143 · COMPLETED

Trial details

NCT number
NCT01690143
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-05-01
Primary completion
2017-11-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.